Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A Plasmodium falciparum infected hepatocyte refers to a host liver cell that has been invaded by the malaria parasite, Plasmodium falciparum. It represents a disease state or cellular condition, serving as the site and cellular context for the parasite's liver stage development, rather than being a discrete molecular therapeutic target itself. The infected hepatocyte provides the environment where the parasite undergoes asexual replication before infecting red blood cells. While it is crucial for studying malaria, therapeutic interventions typically target specific molecular entities within this system, such as host proteins like Scavenger Receptor B1 (SR-B1) or the AIM2 receptor, parasite proteins, or host signaling pathways like the Wnt pathway, which are directly involved in parasite development or host response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum infected hepatocyte.